PROMIS-2

In this medical research study, we aim to assess whether the quality of life in children with cancer can be effectively measured using PROMIS-questionnaires

Recruiting

Who can enter

Parents of children aged 1 to 7 years with cancer
Children and adults aged 8 years and older with cancer

Please note that this study requires that children/parents speak Dutch

Goal

The goal of this study is to determine whether the new PROMIS-questionnaires can accurately measure the quality of life in children with cancer. By "quality of life," we refer to the physical, emotional, and social well-being of the children.

Background

To accurately assess the well-being of children with cancer, it is essential to use reliable questionnaires. Before implementing the PROMIS questionnaires at the Prinses Máxima Center, we need to ensure that these tools effectively measure the quality of life.

In order to participate in a study please refer to your/your child’s doctor.

Last reviewed

March 23, 2026

Study details
Official title
Improving the Measurement of Health-Related Quality of Life Using PROMIS (PROMIS-2): Validation of PROMIS Instruments in the Pediatric Oncology Population
Cancer type
All cancer types
Maximum number of patients
200 parents and 200 children, all in the Netherlands
Start date
October 15, 2024
Status
Open
Local principal investigator
Prof. Dr. M.A. Grootenhuis, Group Leader of Psycho-Oncology
Sponsor
Prinses Máxima Center for pediatric oncology
Approval
This study has been reviewed and approved by the internal scientific committee (Clinical Research Committee) of the Princess Máxima Center. An accredited medical research ethics committee waived the need for official approval according to the Medical Research Involving Human Subjects Act (WMO), and is therefore not further involved in the review of the research. This is only done for studies with low risk or low patient burden. For more information, see: CCMO.